Skip to content
← Full study record

NCT00331760 · OUTCOME

Rate of Disease-free Survival at Five Years

Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery · Source last updated 2019-02-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
From registration five years

What was measured

Disease-free survival time is defined as time from registration to date of failure (any tumor recurrence, development of distant metastases or death from any cause) and is estimated by the Kaplan-Meier method. Patients last known to be alive without failure are censored at the date of last contact.

Analysis population: Eligible patients who started study treatment

Groups in this outcome

Endometrial Cancer: IMRT

Endometrial Cancer patients receive Intensity Modulated Radiation Therapy (IMRT)

Cervical Cancer: IMRT + Chemotherapy (Cisplatin)

Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Endometrial Cancer: IMRT43
Cervical Cancer: IMRT + Chemotherapy (Cisplatin)40

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Endometrial Cancer: IMRT88Not reported7495Not reported
Cervical Cancer: IMRT + Chemotherapy (Cisplatin)84Not reported6892Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        74
        upper Limit
        95
        value
        88
      2. group Id
        OG001
        lower Limit
        68
        upper Limit
        92
        value
        84
denoms
  1. counts
    1. group Id
      OG000
      value
      43
    2. group Id
      OG001
      value
      40
    units
    Participants
description
Disease-free survival time is defined as time from registration to date of failure (any tumor recurrence, development of distant metastases or death from any cause) and is estimated by the Kaplan-Meier method. Patients last known to be alive without failure are censored at the date of last contact.
dispersion Type
95% Confidence Interval
groups
  1. description
    Endometrial Cancer patients receive Intensity Modulated Radiation Therapy (IMRT)
    id
    OG000
    title
    Endometrial Cancer: IMRT
  2. description
    Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)
    id
    OG001
    title
    Cervical Cancer: IMRT + Chemotherapy (Cisplatin)
param Type
NUMBER
population Description
Eligible patients who started study treatment
reporting Status
POSTED
time Frame
From registration five years
title
Rate of Disease-free Survival at Five Years
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice